Bristol-Myers Squibb

Senior Manager, Analytical Engineer

New Brunswick, New Jersey, United States

$120,000 – $160,000Compensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Information Technology, Data Science, AnalyticsIndustries

Requirements

Candidates should possess a Bachelor’s degree in Computer Science, Statistics, Mathematics, or a related field, and have at least 8 years of experience in data engineering, with a strong focus on building and maintaining data models and pipelines. Experience with data warehousing technologies, SQL, and cloud-based data platforms is essential, along with proficiency in data transformation and modeling techniques.

Responsibilities

The Senior Manager of Analytics Engineering will be responsible for designing, developing, and implementing analytical workflows, ensuring that data is clean, well-modeled, and optimized for business intelligence and decision-making. This includes collaborating with the business to gather requirements, building robust and scalable data models and pipelines, and enabling self-service analytics across the organization, while also documenting technical information effectively for various stakeholders.

Skills

SQL
Data Warehousing
Data Modeling
Data Pipelines
Cloud Platforms
Data Transformation
ETL
Data Governance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Key Metrics

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI